Empatica Launches WellPD for At-Home Parkinson’s Monitoring
Boston, Massachusetts, United States, October 28, 2026 Empatica, a company specialising in digital biomarkers and clinical-grade wearable technology, has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Boston, Massachusetts, United States, October 28, 2026 Empatica, a company specialising in digital biomarkers and clinical-grade wearable technology, has...
Seattle, Washington, U.S., September 24, 2026 Atossa Therapeutics Inc. announced that its Chief Executive Officer and Founder, Dr. Steven...
Minneapolis, Minnesota, U.S., September 24, 2026 Marani Health has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
BRIDGEWATER, N.J. and CAESAREA, Israel — September 23, 2026 Theranica announced peer-reviewed results from a study evaluating its Your...
Austin, Texas, U.S., September 18, 2026 Oracle Health and San Juan Regional Medical Center have expanded their collaboration to...
Rehovot, Israel, September 18, 2026 CardiaCare, a medical device company developing wearable technology for cardiac arrhythmias, has announced the...
Singapore and New York, September 16, 2026 KELLS, Inc. has announced that its KELLS AI Dental Scan has been...
Bagsværd, Denmark, September 18, 2026 Novo Nordisk has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Basel, Switzerland, September 18, 2026 Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human...
Boston, Massachusetts, U.S., September 18, 2026 ZBeats, a digital health and medical technology company focused on cardiac diagnostics, has...
